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Facial amphiphilesStructural knowledge of the cystic ﬁbrosis transmembrane conductance regulator (CFTR) requires developing
methods to purify and stabilize this aggregation-prone membrane protein above 1 mg/ml. Starting with green
ﬂuorescent protein- and epitope-tagged human CFTR produced in mammalian cells known to properly fold
and process CFTR, we devised a rapid tandem afﬁnity puriﬁcation scheme to minimize CFTR exposure to deter-
gent in order to preserve its ATPase function. We compared a panel of detergents, including widely used deter-
gents (maltosides, neopentyl glycols (MNG), C12E8, lysolipids, Chaps) and innovative detergents (branched
alkylmaltosides, facial amphiphiles) for CFTR puriﬁcation, function, monodispersity and stability. ATPase activity
after reconstitution into proteoliposomeswas 2–3 times higherwhenCFTRwaspuriﬁedusing facial amphiphiles.
ATPase activity was also demonstrated in puriﬁed CFTR samples without detergent removal using a novel lipid
supplementation assay. By electronmicroscopy, negatively stained CFTR samplesweremonodisperse at low con-
centration, and size exclusion chromatography showed a predominance of monomer even after CFTR concentra-
tion above 1 mg/ml. Rates of CFTR aggregation quantiﬁed in an electrophoretic mobility shift assay showed that
detergents which best preserved reconstituted ATPase activity also supported the greatest stability, with CFTR
monomer half-lives of 6–9 days inMNG or Chaps, and 12–17 days in facial amphiphile. Cryoelectronmicroscopy
of concentrated CFTR in MNG or facial amphiphile conﬁrmed mostly monomeric protein, producing low resolu-
tion reconstructions in conformitywith similar proteins. These protocols canbe used to generate samples of pure,
functional, stable CFTR at concentrations amenable to biophysical characterization.
© 2014 Elsevier B.V. All rights reserved.1. Introduction
The cystic ﬁbrosis transmembrane conductance regulator (CFTR) is a
chloride channel essential to ﬂuid regulation in a number of epithelial
tissues, including lung and intestine. Mutations causing CFTR dysfunc-
tion lead to cystic ﬁbrosis (CF), a genetic disease common in Europe,ansmembrane conductance reg-
eitol; EM, electron microscopy;
ic kidney cells; Inh172, CFTR
A, protein kinase A; PMSF,
sulfate; SEC, size exclusion
).USA, and other populations of European origin [1]. CF represents a se-
vere afﬂiction for which palliative treatment has been the only option,
with the recent exception of Ivacaftor, a drug that improves CFTR func-
tion in patients with the G551D mutation [2]. Ivacaftor shows promise
for other channel gatingmutations as well, but only 4–5% of CF patients
harbor these gating mutations [3]. The most common mutation ac-
counting for 70% of patients, the F508 deletion, results in CFTR
misfolding and its premature degradation [4,5]. At this writing, over
1960 other CFTR mutations have been identiﬁed (www.genet.sickkids.
on.ca) that vary broadly in phenotypic effect, complicating both diagno-
sis and treatment [1]. Expanding effective drug treatment to greater
numbers of CF patients will require intensive drug development effort
which can be facilitated by knowledge of CFTR structure. However,
even wild-type CFTR exhibits conformational instability that renders it
prone to misfold in vivo, as well as to aggregate and lose activity
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for structural and biophysical studies that requiremg/ml concentrations
of pure protein.
CFTR belongs to the ATP-binding cassette (ABC) transporter super-
family of transporters, which possess two transmembrane domains
and two nucleotide binding domains (NBDs) which interact, forming
composite sites of ATP hydrolysis. In CFTR the two nonequivalent
NBDs hydrolyze ATP at different rates [9], and ATP hydrolysis mediates
channel gating [5,10–12]. Another unique feature of CFTR is the R region
whose phosphorylation regulates channel gating through an unknown
mechanism [13]. CFTR NBDs exhibit conformational sensitivity to
many detergents, likely contributing to the great difﬁculty in recovering
active puriﬁed protein [14]. Puriﬁcation of active CFTR from insect and
yeast cells using perﬂuorooctanoate [15] or lysolipid [16–18] has been
reported, but CFTR puriﬁed with these detergents in other laboratories
has proven too unstable for detailed biophysical characterization.
Although human CFTR puriﬁed from mammalian (BHK) cells in
dodecylmaltoside remained functional [19], the preparations were
prone to aggregation and had a concentration limit of 0.3 mg CFTR/ml
[7]. Therefore, identiﬁcation of detergents effective in preserving CFTR
structural and functional integrity remains an urgent priority. Effort in
recent years to develop novel detergents has broughtmanynotable suc-
cesses in structural biology of challengingmembrane proteins [20], and
it is worthwhile to include these in a systematic trial of detergents for
CFTR puriﬁcation.
The expression of modiﬁed human CFTR in human embryonic kid-
ney (HEK) cell line D165 is described in depth elsewhere [EH, HD, A
Mulky, QD, A Aleksandrov, B Bajrami, PA Diego, X Wu, M Ray, AP
Naren, JR Riordan, X Yao, LJD, ILU and JCK, manuscript in preparation].
The recombinant CFTR protein comprises anN-terminal His10 tag linked
to a SUMOstar domain, full length human CFTR with a Flag epitope
inserted proximal to amino acid N901 in the fourth extracellular loop,
and a C-terminal enhanced green ﬂuorescent protein (GFP) domain.
Post-translational modiﬁcations of CFTR that are essential to its matura-
tion and trafﬁcking to the cell surface [5] have been well-characterized
in this expression system [21], and the inserted domains were shown
not to interfere with normal gating of the channel [EH, HD, A Mulky,
QD, A Aleksandrov, B Bajrami, PA Diego, X Wu, M Ray, AP Naren, JR
Riordan, X Yao, LJD, ILU and JCK, manuscript in preparation]. With
CFTR expressed at levels exceeding 1mg per 109 cells, this cell line pro-
vides an ideal starting material for isolation of functional protein. Here
we have devised a simple, rapid protocol for CFTR puriﬁcation from
D165 cell microsomal membranes, utilizing the His10 and Flag epitopes
in a tandem afﬁnity scheme that delivers functionally pure CFTR in 8 to
10 h. Because the protein is also GFP-tagged, recoveries in each step
were readily quantiﬁable. We show that puriﬁed CFTR retains ATPase
activity with or without reconstitution into proteoliposomes, and
compare a panel of detergents for effectiveness in CFTR solubilization,
puriﬁcation, ATPase activity, monodispersity, and stability when con-
centrated above 1 mg/ml. Because of their crucial importance in struc-
tural biology, cutting edge amphiphiles continue to be developed [20].
Among thedetergents tested, our study shows that neopentylmaltoside
detergents (MNGs) [22] are the best overall among the detergents cur-
rently available commercially, and that novel, soon to be available facial
amphiphiles outperform MNGs with regard to CFTR activity and long-
term stability.
2. Materials and methods
2.1. CFTR-expressing cell lines
The inducible HEK293 cell line D165, expressing His10-SUMOstar-
human CFTR901Flag-GFP at the cell surface, is described in detail else-
where [EH, HD, A Mulky, QD, A Aleksandrov, B Bajrami, PA Diego, X
Wu, M Ray, AP Naren, JR Riordan, X Yao, LJD, ILU and JCK, manuscript
in preparation]. The G551D CFTR cell line was generated in the sameway after standard QuikChange mutagenesis. Cells were expanded to
a scale of ~1 l and to a density of 3–5× 106 cells perml. CFTR expression
was induced with 1 μg/ml doxycycline for 36 h.2.2. Cell lysis and membrane isolation
Frozen HEK cell pellets were lysed hypotonically in buffer H (8 mM
Hepes Na pH 7.2/0.8 mM EDTA/1 mM dithiothreitol) containing a mix-
ture of protease inhibitors at the following ﬁnal concentrations: 1 mM
phenylmethylsulfonylﬂuoride (PMSF), 2.5 μg/ml each E64 and
chymostatin, 10 μg/ml each leupeptin and pepstatin A [19,23]. After
douncing, the lysate was promptly mixed with 1/7th vol Buffer H/2 M
sucrose, and centrifuged twice at 1000 × g, 10min. The 1000 × g super-
natant was ultracentrifuged 1 h at 100,000 × g. The resulting pellet was
washed by resuspension in 50 mM Tris Cl pH 7.5/0.5 M NaCl/10% glyc-
erol/1 mM dithiothreitol (DTT) containing protease inhibitor mixture
and ultracentrifugation for 1 h at 100,000 × g. All centrifugation steps
used slow braking. The ﬁnal membrane pellet was resuspended in Buff-
er S (50 mM Tris Cl pH 8.0/0.2 M NaCl/10% glycerol/1 mM DTT) with
protease inhibitor mixture. Aliquots were frozen at−80 °C. The proce-
dure yielded 30 ± 8 mg microsomal protein per 109 cells.2.3. CFTR quantitation by in-gel GFP ﬂuorescence
CFTR quantitation by in-gel GFP ﬂuorescence is based on an
established method [24]. Samples were separated on 8% SDS-PAGE
gels, and ﬂuorescent images were recorded using a scanner or digital
camera with FITC ﬁlter set. Each gel included known amounts of an ex-
ternal standard, either Sumo-GFP (LifeSensors, 39 kD) or mouse P-
glycoprotein-GFP fusion protein (172 kD) puriﬁed in our lab. Exposure
times were adjusted so that ﬂuorescence intensity fell within the linear
range. Fluorescent bands were quantitated by densitometry using the
public domain application Image J (http://imagej.nih.gov/ij/index.
html). Amounts of CFTR (212 kD) were calculated from the linear stan-
dard curve, taking into account its molecular weight difference. After
image capture, gels were silver stained to assess sample purity [25].2.4. Tandem afﬁnity puriﬁcation
Membranes were adjusted to 2 mg/ml in Buffer S (Section 2.2) also
containing 10 mM imidazole, 2.5 mM MgCl2, 1 mM ATP, and protease
inhibitor mixture. Detergent was added to give 0.5% (w/v). After
30min incubation on icewith periodic mixing, the suspensionwas cen-
trifuged 30 min at 100,000 × g with slow deceleration. The detergent
extract was diluted 5-fold in Buffer S containing 10 mM imidazole,
2.5 mM MgCl2, 1 mM ATP, and 0.1 mM PMSF. If necessary, detergent
was included in this mixture to keep detergent at the working concen-
tration; these working concentrations are stated in Table 1. All subse-
quent buffers contained detergent at the working concentration.
NiNTA resin (Qiagen Superﬂow) was added to give 1% (v/v), and after
3 h gentle rotation at 4 °C the binding mixture was packed into a chro-
matography column under gravity ﬂow. The resin was washed with 30
vol Buffer W (50 mM Tris Cl pH 7.5/10% glycerol/2.5 mMMgCl2/1 mM
ATP) containing 0.5 M NaCl and 60 mM imidazole, then 10 vol Buffer
W with 0.15 M NaCl and 60 mM imidazole. The column was eluted
over 30 min with 4–5 vol Buffer W containing 0.15 M NaCl and
350 mM imidazole. NiNTA eluate was mixed with 1/5th vol of a 50%
antiFlag gel suspension (Sigma A2220) at 4 °C for 90 min, then trans-
ferred to a column. The antiFlag columnwas washed with 10 vol Buffer
W with 0.5 M NaCl, then 10 vol Buffer W with 0.15 M NaCl. CFTR was
eluted over 25 min with 5 vol of the ﬁnal wash solution containing
0.1 mg/ml DYKDDDDK. Upon completion, 1 mM DTT was added to
the ﬁnal eluate.
Table 1
Detergents surveyed, and CFTR recoveries in solubilization and tandem afﬁnity puriﬁcation.
Detergent Abbrev CMC (w/v) Working conc
(w/v)
CFTR
solubilized
Overall CFTR recovery
Method 1 Method 2
1-Myristoyl-2-hydroxy-sn-glycero-3-phosphocholine lysoPC14 0.003%b 0.05% nd nd nd
1-Palmitoyl-2-hydroxy-sn-glycero-3-phosphocholine lysoPC16 0.0002%a 0.05% 83 ± 24% 1.1 ± 0.6% nd
1-Myristoyl-2-hydroxy-sn-glycero-3-phospho-(1′-rac-glycerol) lysoPG14 0.0003%b 0.05% nd nd nd
Dodecyl octaethylene glycol ether C12E8 0.005%a 0.05% 78 ± 20% 5.7 ± 0.9% nd
1-Decyl-β-D-maltoside DM 0.09%a 0.3% 78 ± 19% 6.2 ± 1.8% nd
1-Undecyl-β-D-maltoside UDM 0.03%a 0.1% 66 ± 14% 4.9 ± 1.4% nd
1-Dodecyl-β-D-maltoside DDM 0.01%a 0.05% 71 ± 14% 5.0 ± 1.2% nd
1-Tridecyl-β-D-maltoside TDM 0.001%a 0.05% 62%d nd nd
3-Tridecyl-β-D-maltoside Mal 11-2 0.006%b 0.05% 58 ± 11% 2.4 ± 1.0% nd
2-Tetradecyl-β-D-maltoside Mal 12-1 0.004%b 0.05% 62 ± 17% 6.0 ± 1.9% nd
3-Tetradecyl-β-D-maltoside Mal 12-2 0.001% [31] 0.05% 28 ± 7% 1.1 ± 0.6% nd
5-Cyclohexyl-1-pentyl-β-D-maltoside Cymal 5 0.12%a 0.4% 57 ± 23% 5.1 ± 1.2% nd
6-Cyclohexyl-1-hexyl-β-D-maltoside Cymal 6 0.03%a 0.1% 60 ± 10% 4.4 ± 1.4% nd
7-Cyclohexyl-1-heptyl-β-D-maltoside Cymal 7 0.01%a 0.05% 71 ± 15% 4.8 ± 0.9% nd
Decyl maltose neopentyl glycol MNG10 0.003% [22] 0.05% 53 ± 9% 3.8 ± 1.3% nd
Lauryl maltose neopentyl glycol MNG12 0.001% [22] 0.05% 45 ± 13% 4.4 ± 1.7% nd
3-[(3-Cholamidopropyl)-dimethylammonio]-1-propanesulfonate Chaps 0.5% 1% 35 ± 8% nd 6.3 ± 1.5%
3α,7α,12α-Tri((O-β-D-maltopyranosyl)ethyloxy)-17-(pentan-2-yl)-cholane FA-4 0.028% [32] 0.05% 6%d 0.3%d 7.4 ± 2.5%
3α,7α,12α-Tri((O-β-D-maltopyranosyl)ethyloxy)-17-(hexan-2-yl)-cholane FA609 0.009%c 0.05% 12%d 0.2%d 6.5 ± 1.1%
3α,7α,12α-Tri((O-β-D-maltopyranosyl)ethyloxy)-17-(heptan-2-yl)-cholane FA611 0.004%c 0.05% 20%d 1.1%d 6.9 ± 2.7%
3α,7α,12α-Tri((O-β-D-maltopyranosyl)ethyloxy)-17-(6-methylheptan-2-yl)-cholane FA613 0.001%c 0.05% 22%d 1.6%d 7.9 ± 3.1%
Generalized structures for detergent families are shown in Fig. 3. CFTR was extracted frommicrosomes at 0.5% detergent. Chromatography was conducted at the stated working concen-
trations, whichwere selected to be just above the CMC or no less than 0.05%. Inmethod 1, the same detergentwas used for solubilization and for chromatography. Inmethod 2, UDMwas
used for solubilization and a second detergentwas used for chromatography. Overall recoveries refer to amount of CFTR recovered from theﬁnal afﬁnity step compared to CFTR present in
the starting microsomal membranes. Values represent mean ± standard deviation for three or more trials, except as noted.
nd: not done.
a www.anatrace.com.
b avantilipids.com.
c Determined as described in Section 2.11.
d Result in a single trial.
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We chose Biobeads for reconstitution because this detergent removal
method is applicable evenwith very lowCMCdetergents [26]. Several el-
ements of this protocol were systematically varied, including lipid com-
position, lipid:protein ratio, and rate of detergent removal; we found the
factor most strongly inﬂuencing downstream results to be the use of
C12E8 for pre-destabilizing liposomes. Sonicated liposomes were
prepared from a 5:3:1:1 or 5:1:3:1 mixture by weight of 1-palmitoyl-
2-oleoyl-phosphatidylethanolamine, brain phosphatidylserine, egg
phosphatidylcholine (all phospholipids from Avanti Polar Lipids), and
cholesterol (Anatrace) [16,18,19]. Liposomes were destabilized on the
day of use by addition of C12E8 at a detergent:lipid ratio of 1:4 w/w, incu-
bated at room temperature for 1 h, then chilled until use. Puriﬁed CFTR
(150–200 μl, ~5 μg) was mixed with 400 μg of destabilized liposomes at
4 °C for 30min, then four equal additions of polystyrene beads (Biobeads
SM2, Biorad) were made at intervals over the next 15–20 h [26]. A total
30-fold bead excess was used, assuming a detergent capacity of
100 μg/mg [27]. Mock proteoliposomes were prepared in parallel
using column elution buffer without Flag peptide, which had no effect
on assay background. Proteoliposome and mock samples were then di-
luted in 20 vol 20 mM Tris Cl pH 7.5/0.15 M NaCl/2.5 mMMgCl2/1 mM
DTT, ﬁltered to remove beads, collected by ultracentrifugation at
200,000 × g, and resuspended in 1/5th–1/10th the original eluate
volume of Buffer A (25 mM Tris Cl pH 7.5/0.2 M NaCl/2.5 mM
MgCl2/1 mM DTT).
2.6. ATPase activity measurements
2.6.1. ATPase assay
Proteoliposomes and mock samples were incubated with 0.3 mM
[α32P]-ATP at 33 °C for 2 h. If necessary, sampleswere dilutedwith Buff-
er A (Section 2.5) so that substrate conversion did not exceed 10%. A 1 μl
portion of each incubation was quenched with 1 μl of 10% SDScontaining 10 mM ATP and 10 mM ADP, and half was spotted onto
polyethyleneimine-cellulose TLC plates with ﬂuorescent indicator [17].
After development in 1 M HCOOH/0.5 M LiCl, the ATP and ADP spots
were cut and counted in 4 ml Ecolume (MP Biomedicals), and product
formation was calculated from the observed ADP/ATP ratio. Blank
rates (nmol/h) measured in mock samples under each test condition
were subtracted before calculating speciﬁc enzymatic activities.
To directly assay antiFlag eluates without reconstitution, ATP was
omitted from antiFlag chromatography buffers. Samples or mock sam-
ples were supplemented with 2 mg/ml C12E8-destabilized liposomes
(described in Section 2.5) and preincubated on ice for 45–60 min prior
to substrate addition as above. Control experiments showed that prod-
uct formation was proportional to CFTR concentration.
2.6.2. Michaelis–Menten kinetic measurements
CFTRwas phosphorylated or dephosphorylatedwhile NiNTA-bound.
In control experiments, silver staining showed that this approach
allowed complete removal of the modiﬁcation enzymes from puriﬁed
CFTR prior to its reconstitution, and CFTR bands demonstrated the ap-
propriate mobility shifts. After the ﬁrst 0.5 M NaCl wash (Section 2.4),
the NiNTA column was washed with 10 vol 50 mM Tris Cl pH 7.5/0.15
M NaCl/10% glycerol/5 mM MgCl2/1 mM ATP, then resuspended in 1
vol of the same solution containing either 500 U/ml protein kinase A
catalytic subunit (PKA, Promega) or 4mMMnCl2 and 4000U/ml lambda
protein phosphatase (New England Biolabs). Enzymatic treatments
were for 20 min at 4 °C, followed by NiNTA washing with 10 vol Buffer
W at 0.15 M NaCl and 60 mM imidazole. Elution, antiFlag chromatogra-
phy and reconstitutionwere completed as described in Sections 2.4 and
2.5. Washed proteoliposomes were resuspended in Buffer A containing
6 mM MgCl2 and assayed at ATP concentrations varying from 0.3 to
2.4 mM. Km and Vmax were obtained by least squares ﬁtting of the
Michaelis–Menten equation. Allowing Hill coefﬁcients to differ from
unity did not alter the curve ﬁts.
Fig. 1. Minimum effective detergent concentrations for CFTR solubilization. CFTR-
expressing D165 cell microsomes (2 mg/ml) were incubated with the indicated concen-
trations of detergent (w/v) on ice for 30 min, then centrifuged 20 min at 100,000 × g.
CFTR concentrations in supernatants or in microsomes dissolved in SDS sample buffer
were determined by in-gel ﬂuorescence (Section 2.3). OG: Octylglucoside.
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Samples of microsomes, proteoliposomes, or mock proteolipo-
somes in DTT-free buffer A were incubated on ice for 5 min with
0.1 mM 8-azidoadenosine 5′-triphosphate 2′,3′-biotin-long chain
hydrazone (8-azido-ATP-biotin, Afﬁnity Photoprobes) in the presence
or absence of 10 mM competitor ATP. The mixtures were irradiated on
ice for 40 s at 254 nm in a UV Products crosslinker set at 120,000 J/cm2,
then quenched by addition of 50 mM DTT in SDS-gel sample buffer.
After resolution on an 8% SDS gel, proteinswere transferred to nitrocellu-
lose. Photoafﬁnity nucleotide labeled protein was detected with horse-
radish peroxidase-conjugated goat antibiotin (1:6000 in 1% milk, 1 h),
with chemiluminescent detection.
2.8. Electron microscopy (EM)
Upon completion of tandem afﬁnity puriﬁcation, samples of CFTR in
various detergents were brought to 1 mM DTT, and rapidly frozen for
shipment. These low concentration samples were examined by nega-
tively stained EM as described previously [28]. For cryoelectronmicros-
copy, PKA-phosphorylated, tandem afﬁnity puriﬁed CFTR samples were
concentrated as described in Section 2.9, then buffer-exchanged on the
ultraﬁlter into modiﬁed Buffer W containing 8% glycerol, 0.15 M NaCl,
1 mM DTT, and detergent at working concentration. Samples were rap-
idly frozen by plunge-freezing into liquid ethane and examined using an
FEI Polara transmission electron microscope operated at 200 kV as de-
scribed previously [7] but with strong underfocus (N4 μm) employed
during imaging because of the relatively smallmass of the particles. Par-
ticleswere selected from4 k×4 k images using the autoboxing function
of the EMAN2 software suite and subsequently processed using the
same software [29]. Resolution of the ﬁnal 3D reconstructions was esti-
mated at 3.5–4.0 nm.
2.9. Concentration and size exclusion chromatography
NiNTA-puriﬁed CFTR (at least 80% pure by silver stain) was reduced
with 1 mM DTT, then gradually concentrated by successive spins in
100,000 MWCO spin concentrators (Amicon Ultra, Millipore), sampling
the retentate at stages along theway. These sampleswere promptly fro-
zen, and later analyzed for the presence of monomer, multimer, and
void volume aggregates by size exclusion chromatography (SEC) on a
3.2 mm × 30 cm Superose 6 column (GE Healthcare) [30]. SEC buffer
was 50 mM Tris Cl pH 7.5, 0.15 M NaCl, 10% glycerol, 2.5 mM MgCl2,
0.05% MNG10, 0.2 mM tris(2-carboxyethyl)phosphine, ﬂowing at
0.04 ml/min. GFP ﬂuorescence was monitored at 488 nm/509 nm
using a Jasco FP2020 Plus ﬂuorimetric detector, with gain set at 100
and attenuation at 64.
2.10. Measurement of CFTR aggregation rates by electrophoretic mobility
shift
To compare CFTR stability after concentration in detergents, NiNTA-
puriﬁed CFTRwas concentrated as in Section 2.9. Tomatch buffer condi-
tions in cryoEM and SEC analyses, the retentate was washed twice in
Buffer W (Section 2.4) with 0.15 M NaCl, 1 mM DTT, and detergent at
working concentration, then concentrated to minimum volume. The
retentate was sampled immediately and after 1, 4, and 7 days of 4 °C
storage. These samples were diluted 15-fold into SDS-gel sample buffer
for quantitation of CFTR monomer band by in-gel ﬂuorescence
(Section 2.3). Themethod thereforemeasures CFTR that has not entered
into SDS-resistant complexes.
2.11. Reagents
Branched-chain maltosides used in this work were synthesized as
previously described [31]. Mal 11-2 and 12-1 have recently becomecommercially available from Avanti Polar Lipids. Facial amphiphiles FA
609, 611, and 613 were prepared similarly to FA-4 [32], starting from
3α, 7α, 12α-trihydroxycholane bearing different alkyl chains that
were prepared by one-step Kolbe electrolysis reaction of cholic acid
and aliphatic carboxylic acids [32]. Facial amphiphiles are currently
under commercial development by Avanti Polar Lipids. Their criticalmi-
celle concentrations (CMCs)were determined by a standard ﬂuorescent
dye binding protocol using 8-anilino-1-naphthalenesulfonic acid [33].
Other maltoside detergents, Chaps, and C12E8 were from Anatrace, and
lysolipids were from Avanti Polar Lipids.
Inhibitor sourceswere sodium azide (N99%, ThermoFisher), ouabain
(Sigma), and CFTR Inhibitor 172 (Calbiochem).
2.12. Statistical comparisons
Statistical comparisons were made using Student's two-tailed t-test.
3. Results
In selecting detergents for this surveywe focused onmild detergents
with a record of success in conservingmembrane protein structure and
function. Detergents were tested for effectiveness in CFTR puriﬁcation
and for retention of ATPase activity. Those which performed well in
the functional assessment were evaluated for CFTR stability, which in-
cluded concentration of CFTR, assessments of monodispersity, and pro-
tein aggregation rate.
3.1. Rapid CFTR puriﬁcation scheme
In this study we have prioritized the quality of puriﬁed protein over
quantity. The strategy behind our puriﬁcation scheme was to minimize
both detergent concentration and duration of exposure, throughout ini-
tial CFTR solubilization and chromatography. We began by titrating a
limited set of detergents commonly used for membrane protein puriﬁ-
cations to determine the lowest effective detergent:protein ratios for
CFTR solubilization from microsomes, utilizing C-terminal GFP domain
ﬂuorescence for quantitation. This analysis (Fig. 1) showed the effec-
tiveness of mild detergents such as DDM or C12E8 in extracting 70–
90% of CFTR even at low detergent:protein ratios. On the other hand,
octylglucoside or Chaps extracted no more than 30–50% of CFTR even
at detergent concentrations as high as 2%. The neopentyl maltoside de-
tergent MNG10 [22] demonstrated intermediate effectiveness. In
Fig. 2. Functional purity of puriﬁed, reconstituted CFTR. CFTR (212 kD) was puriﬁed in parallel either in MNG10 or in C12E8, then reconstituted into proteoliposomes. Panel A: Samples of
CFTR at the following stages of puriﬁcation were resolved on an 8% SDS-gel and silver stained: starting material (microsomes, 5 μl), detergent extracts (5 μl), NiNTA column and antiFlag
column eluates (5 μl), and reconstituted proteoliposomes (0.2–0.3 μg CFTR). Sizes of ﬂanking molecular weight markers, in kD, are indicated at the left and right. For clarity, staining of
lanes containing microsomes and extract was terminated sooner than the puriﬁed samples. Panel B: The proteoliposome samples shown in panel A, or mock proteoliposomes, were
used for photoafﬁnity nucleotide labeling in the presence or absence of 10 mM competitor ATP, as described in Section 2.7. A fresh aliquot of microsomes from the same batch used as
starting material in CFTR puriﬁcation was included as a labeling control. Sample load per lane was 60 μg (total protein) microsomes, 1.7 μg CFTR (MNG10) or 1.2 μg (C12E8), or the equiv-
alent volume of mock proteoliposomes. The arrowhead at the right shows the position of the uppermost prestained marker band in an adjacent lane of the Western blot.
2829E. Hildebrandt et al. / Biochimica et Biophysica Acta 1838 (2014) 2825–2837general, increasing the detergent:protein ratio from 2.5 (w/w) to 5 or
even 10 extracted little additional CFTR, and so a low detergent:protein
ratio of 2.5 was selected for CFTR solubilization throughout all subse-
quent studies. In addition, we carried out solubilizations at low proteinFig. 3. Detergent types compared in this study. Chemical names of individual detergents, their
feature the canonical polar head/apolar tail arrangement, except facial amphiphiles which comconcentration (2 mg/ml) to allow the use of low detergent concentra-
tion (0.5%) while maintaining that ratio. Immediately after clariﬁcation
of extraction mixtures by ultracentrifugation, extracts were diluted 5-
fold, bringing the detergent to 0.1% during batchwise NiNTA binding.C12E8
CMC values, and working concentrations used in this study are speciﬁed in Table 1. Most
bine side polarity with a hydrophobic rigid steroid moiety.
Fig. 4. CFTR modiﬁcations that alter rates of ATP hydrolysis. CFTR was puriﬁed in MNG10
and reconstituted into proteoliposomes. Rates of ATP hydrolysis were measured vs. ATP
concentration to derive Michaelis–Menten parameters. Each experiment shown was rep-
licated in three independent trials with comparable results. Panel A: Wild-type CFTR and
the mutant G551D were PKA-phosphorylated in vitro, puriﬁed, and reconstituted. Equal
volumes were assayed in parallel. The CFTR mutant showed markedly reduced rates of
ATP hydrolysis. Inset: Silver stain of proteoliposome samples, equal volumes loaded in
each lane. Panel B: Portions ofwild-type CFTRwere either PKA phosphorylated or dephos-
phorylated in vitro. After puriﬁcation and reconstitution, these modiﬁcations were shown
to alter ATP hydrolysis rates. Inset: Silver stain showing difference in electrophoretic mo-
bility of puriﬁed CFTR due to alterations in the degree of phosphorylation.
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did increase CFTR recovery, this came at the expense of function (data
not shown). NiNTA afﬁnity puriﬁcation achieved ~80% CFTR purity
(Fig. 2A), which we considered insufﬁcient for the measurement of
ATPase activity because CFTR cannot be selectively assayed. We there-
fore introduced an antiFlag immunoafﬁnity chromatography step that
improved purity to ~95% as judged by silver staining (Fig. 2A). Time
elapsed from membrane solubilization to antiFlag elution was typically
8–10 h.
We utilized this tandem afﬁnity scheme to assess the effectiveness
of a panel ofmild detergents for CFTR puriﬁcation (Table 1). General de-
tergent structures are shown in Fig. 3. Purity of CFTR preparations
throughout the study was veriﬁed by silver staining. Regardless of de-
tergent choice, ~95% purity was consistently achieved using the rapid
tandem afﬁnity puriﬁcation scheme (Figs. S1, 2A, and other data not
shown). With limited opportunity for binding to afﬁnity matrices,
CFTR recoveries averaged 23–33% for each afﬁnity stepwhich, in combi-
nation with partial solubilization, gave overall recoveries (Table 1) in
the 5% range (2–3 μg CFTR per mg starting membrane protein, or
75 μg per 109 cells). Use of mild detergents such as C12E8 or a broad va-
riety of maltoside detergents led to much higher recovery of puriﬁed
CFTR than was obtained using lysolipids, despite the latter's effective-
ness for CFTR solubilization (Table 1, and other data not shown). CFTR
recoveries were somewhat lower with neopentyl (MNG) detergents
than with n-alkylmaltosides or Cymals. With branched alkylmaltosides
Mal 11-2, 12-1, and 12-2, recoveries varied quite strongly with alkyl
chain length, the 12-1 conﬁguration providing themost satisfactory re-
covery of CFTR. Like Chaps, sterol-based facial amphiphiles FA-4, FA609,
FA611 and FA613 proved to be ineffective CFTR solubilizers, extracting
b22%. Because these new facial amphiphiles exhibit unique favorable
properties [20,32], we tested them by carrying out solubilization in
UDM, then exchanging into the facial amphiphile or Chaps detergent
during column washing (Table 1, method 2). In this approach, CFTR re-
coveries were signiﬁcantly higher using facial amphiphile for chroma-
tography than using UDM (P b 0.015), and were the highest CFTR
recoveries achieved in the study. Exchange into Chaps gave only mar-
ginal improvement (P = 0.028).
3.2. Control experiments to validate function
To assess the functional integrity of CFTR obtained with our rapid
puriﬁcation procedure, we reconstituted CFTR into proteoliposomes
and compared its functional characteristics to those previously
reported.
3.2.1. Photoafﬁnity labeling of nucleotide binding sites
ATP binding and hydrolysis regulate CFTR channel activity [11,12,34].
To demonstrate functional purity, two preparations of CFTR puriﬁed in
either C12E8 orMNG10were reconstituted into proteoliposomes, then la-
beled with 8-azido-ATP-biotin (Fig. 2B). Whereas the photoafﬁnity re-
agent labeled a great number of ATP-binding proteins in microsomal
membranes, only the CFTR band was labeled in puriﬁed, reconstituted
preparations. Based on the absence of other ATP-binding entities, ATPase
activity detected in puriﬁed, reconstituted CFTR (Sections 3.2.2 and 3.3)
would be unlikely to arise from contaminant proteins. Greater labeling
of reconstituted CFTR was observed following puriﬁcation in MNG10
than in C12E8, reﬂecting better preservation of NBD function which was
also manifest in greater ATPase activity (Section 3.3).
3.2.2. Validation of CFTR-speciﬁc ATP hydrolysis
G551D is a cystic ﬁbrosis-causing CFTR mutation that reduces ATP
binding and hydrolysis [35,36]. As a second check that ATP hydrolysis
was CFTR-speciﬁc, we expressed G551D CFTR in HEK cells, and afﬁnity
puriﬁed and reconstituted the mutant protein in parallel with wild-
type CFTR. ATPase activitiesweremeasured over a range of ATP concen-
trations using protein that had been PKA-phosphorylated, as explainedbelow. Fig. 4A shows a representative result. Wild-type CFTR exhibited
Km=0.4± 0.1mM and Vmax= 1.4± 0.5 nmol/h/μg (n= 4). ATPase
activity of the G551Dmutantwasmarkedly reduced compared to paral-
lel wild-type preparations, such that kinetic parameters could not be re-
liably determined. In triplicate experiments, the hydrolysis rate at
2.4 mM ATP for G551D was 14 ± 12% of the wild-type rate.
Protein kinase A (PKA) regulates CFTR gating in intact cells [5,11],
but reports differ as to the inﬂuence of PKA phosphorylation on CFTR's
in vitro ATPase activity [17,36]. To investigate this, parallel CFTR sam-
ples in MNG10 were either dephosphorylated or PKA-phosphorylated
while NiNTA-bound, an approach that allowed complete washout of
the modiﬁcation enzymes which were undetectable by silver staining.
Appropriate SDS gel mobility shifts due to changes in CFTR phosphory-
lation state were observed (Fig. 4B, inset). After immunoafﬁnity puriﬁ-
cation and reconstitution, we determined ATPase activity vs. ATP
concentration for the phosphorylated and dephosphorylated samples;
Fig. 5. The detergent used for CFTR puriﬁcation inﬂuences reconstituted ATPase activity.When CFTRwas puriﬁed in facial amphiphiles or Chaps, UDMwas used for initial solubilization; in all
other trials, a single detergent was used for both solubilization and chromatography. After reconstitution into proteoliposomes, ATPase activities were measured in ﬁxed-time assays at
0.3 mM ATP, controlling the amount of material assayed so that conversion of substrate to product did not exceed 10%. Each trial included duplicate samples from four to six parallel puri-
ﬁcations/reconstitutions, eachwith matching mock samples serving as assay blanks. The complete analysis entailed combining data from a large number of trials, and so to manage day-to-
day variability all trials included a reference condition, namely use of UDM throughout solubilization and puriﬁcation, and speciﬁc ATPase activities were normalized to these reference sam-
ples. Speciﬁc activity for reference samples averaged0.19±0.04 nmol/h/μg (n=16). Combineddata from three ormore independent trials of eachdetergent are shownasmean± standard
deviation, with the number of trials shown in the ﬁgure.
2831E. Hildebrandt et al. / Biochimica et Biophysica Acta 1838 (2014) 2825–2837Fig. 4B shows a representative result. In accord with PKA regulation of
CFTR gating, ATPase activity of puriﬁed reconstituted CFTRwas strongly
enhanced by PKA phosphorylation compared to the dephosphorylated
state, for which kinetic parameters could not be reproducibly deter-
mined. In triplicate experiments, dephosphorylated CFTR hydrolyzed
2.4 mM ATP at 30 ± 8% the rate for PKA-phosphorylated CFTR. CFTR is
highly phosphorylated in HEK cells [21], andwe later found that ATPase
activity could be readily measured in these reconstituted and rapidly
puriﬁed preparations without in vitro phosphorylation (Sections 3.3,
3.4).Table 2
Conditions for measurement of ATPase activity directly in detergent solution.
Supplement added ATPase, nmol/h/μg
Puriﬁed in FA-4 Puriﬁed in MNG10
Wild-type G551D Wild-type G551D
Buffer 0.005 0.012 0.024 0.006
Untreated liposomes 0.013 0.015 0.094 0.040
C12E8-destabilized liposomes 0.150 0.040 0.143 0.054
C12E8 only 0.001 0.012 0.009 0.005
Wild-type and G551D CFTR were tandem afﬁnity-puriﬁed in parallel in the indicated de-
tergents. AntiFlag eluates were supplemented with 2 mg/ml untreated liposomes, with
2 mg/ml C12E8-destabilized liposomes (Section 2.5), or an equivalent amount of C12E8
(0.5 mg/ml) 45 min prior to assay at submaximal ATP (0.3 mM), as described in Section
2.6.1. Values shown are the average of duplicates that differed by no more than 6%.3.3. Survey of detergents for preservation of CFTR function
To assess the retention of function for a panel of detergents, we com-
pared ATPase activity among reconstituted CFTR preparations (Fig. 5).
Among conventional linear alkylmaltoside detergents, signiﬁcantly
higher ATPase activitywas recovered using UDMorDDM for puriﬁcation
compared to their shorter-chain counterpart DM, a trend also observed
among cyclohexylmaltosides (Cymal 6 and 7 vs. Cymal 5). The shorter
chain detergents have higher CMC values, and observed differences in
ATPase activitymight be due to increased detergent exposure at the nec-
essarily higher detergent concentrations used during chromatography.
Puriﬁcation of CFTR in lysoPC, despite its low CMC, resulted in quite
low reconstituted ATPase activity, suggesting loss of conformation such
as that demonstrated when isolated NBDs of CFTR were exposed to
this detergent [14]. Among widely used detergents, MNGs, DDM, and
Chaps preserved the highest CFTR ATPase activities. They were rivaled
by novel branchedmaltosides (Mal 11-2, Mal 12-1, Mal 12-2) for ATPase
retention, and two of these compounds recently became available com-
mercially. The highest reconstituted ATPase activity, by a factor of 2–3,
was seen with CFTR puriﬁed in facial amphiphiles (FA-4, FA609, FA611,
FA613). These novel amphiphiles (currently undergoing commercializa-
tion) are structurally unique (ﬁg. 3) and are often less denaturing, attrib-
uted to their rigid hydrophobic steroid moiety [32].3.4. Conditions for direct measurement of ATPase without reconstitution
We discovered conditions permitting assay of CFTR ATPase activity
directly in detergent solution, without laborious reconstitution. This re-
quired supplementation with C12E8-destabilized liposomes (Table 2).
Other destabilizing detergents failed to substitute for C12E8 in making
the lipid supplement effective (data not shown), perhaps owing to the
unique bilayer-destabilizing properties of polyoxyethylene detergents
[26,37]. With detergent removal omitted, detergent effects on activity
are possible, and therefore this expedient assay is more suited for stud-
ies in a single detergent. For example, we used the direct assay to mea-
sure ATPase activity of puriﬁed samples before and after freezing at
−80 °C, in each case supplementing with destabilized lipid 45 min
prior to assay.We found that CFTR puriﬁed inMNG10or in FA4 retained
94% and 95% of initial ATPase activity through the freeze/thaw cycle.
This simple observation would have been considerably more arduous
using non-simultaneous reconstitutions.
In a second application, we used selective inhibitors to test for the
presence of contaminating ATPase activities at successive stages of
CFTR puriﬁcation in FA-4 (Table 3). Samples puriﬁed by NiNTA only or
Table 3
Differential inhibitor sensitivities of NiNTA-puriﬁed and tandem afﬁnity-puriﬁed CFTR preparations.
Inhibitor Partially puriﬁed (NiNTA only) Tandem afﬁnity puriﬁed (NiNTA/antiFlag)
ATPase, % of control P vs vehicle ATPase, % of control P vs vehicle P vs partially puriﬁed
2 mM NaN3 {water} 78 ± 5% (4) 0.003 98 ± 3% (4) ns 0.0005
5 mM NaN3 {water} 80 ± 4% (4) 0.002 98 ± 3% (4) ns 0.0004
2 mM ouabain {0.5% DMSO} 98 ± 4% (4) ns 101 ± 2% (4) ns ns
5 mM ouabain {1.2% DMSO} 93 ± 4% (4) ns 95 ± 2% (4) ns ns
20 μM Inh172 {1% DMSO} 90 ± 1% (4) ns 81 ± 5% (5) 0.002 0.01
50 μM Inh172 {2.5% DMSO} 74 ± 5% (4) 0.008 64 ± 5% (5) 0.0001 0.02
1% DMSO 97 ± 6% (4) 94 ± 2% (4) ns
2.5% DMSO 91 ± 7% (4) 85 ± 2% (4) ns
CFTR was puriﬁed from UDM extract in FA-4 by NiNTA chromatography or by tandem NiNTA/antiFlag chromatography. 1 mM ATP was included during binding to afﬁnity matrices but
omitted from chromatography buffers. Samples of NiNTA eluate (diluted 1:5 with buffer) or antiFlag eluate were mixed with 2 mg/ml C12E8-destabilized liposomes (Section 2.5), then
with inhibitor, and preincubated on ice for 60 min prior to substrate addition and assay as in Section 2.6.1. Ouabain and Inh172 stocks were prepared in DMSO; vehicle concentrations
in the assay are stated in curly brackets. Combined results of n replicate assays are shown. Control ATPase activity (no inhibitor) averaged 0.34 ± .04 nmol/h/μg for partially puriﬁed
CFTR and 0.16 ± .02 nmol/h/μg for tandem afﬁnity puriﬁed CFTR, under these submaximal assay conditions.
ns: not statistically signiﬁcant.
Fig. 6. Puriﬁed CFTR hydrolyzes ATP in the presence of detergents. Tandem afﬁnity-
puriﬁed CFTR samples, as eluted from antiFlag columns, were preincubated with
destabilized liposomes. ATPase activities were then assayed at 0.3 mM ATP. Combined
data from replicate experiments are shown as mean ± sd, with the number of repeat ex-
periments for each detergent shown in the ﬁgure. A single batch of microsomes was used
as source material for this group of experiments.
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hibitors in the presence of destabilized liposomes, thenATPase activities
measured in the direct assay. Neither CFTRpreparationwas inhibited by
ouabain, indicating the absence of plasma membrane Na/K ATPase.
NiNTA-puriﬁed CFTR retained signiﬁcant (P b 0.003) sensitivity to
azide, an inhibitor ofmitochondrial F-type ATPase, whereas the antiFlag
step removed this azide-sensitive contaminant (P b 0.0005). CFTR In-
hibitor 172 (Inh172) [38–40] was reported to partially inhibit CFTR
ATPase function [41]. Preincubation with Inh172 signiﬁcantly inhibited
CFTR ATPase activity in the direct assay (P b 0.002). Partially puriﬁed
CFTR was signiﬁcantly less sensitive to Inh172 (P b 0.01), as would be
expected for an impure sample.
Not all detergents worked equally well in the direct assay, and this
depended strongly on both detergent structure and alkyl chain length.
CFTR puriﬁed in MNG10 or in facial amphiphiles showed the highest
ATPase activities in this assay, while lower activities measured in the
presence of other detergents suggested inhibitory effects in those
cases (Fig. 6).
3.5. Monodispersity of CFTR puriﬁed in select detergents before and after
concentration
While retention of CFTR function is important, structural characteriza-
tionwill require additional favorable properties such asmonodispersity at
high protein concentration. CFTR preparations puriﬁed in several deter-
gents were evaluated initially at low concentration (20–30 μg/ml) by
negative staining and transmission EM (Fig. S2). For all of the puriﬁcation
detergents tested, these images demonstrated little evidence ofmajor ag-
gregates. CFTR particle widths were similar in all detergents tested and
ranged from 5 to 12 nm. Particles of 10–12 nm diameter have previously
been identiﬁed as CFTR dimers [7,28].
To assess the behavior of CFTR at higher protein concentrations,
samples of CFTR puriﬁed inMNG10 or FA-4were concentrated by ultra-
ﬁltration to 1.8 and 3.1 mg CFTR/ml, respectively. Concentration
proceeded smoothly without overt evidence of aggregation, such as
cloudiness or blocking of the ultraﬁlters. CryoEM of these samples like-
wise showed little evidence of aggregation; Fig. 7 shows results for the
sample in FA-4, and results for MNG10were comparable. A monomeric
CFTR particle, including mass of bound detergent, would be approxi-
mately 250 kD. Assuming that CFTR has a typical ABC transporter struc-
ture, monomers would approximate to cylinders 11 nm long and 6 nm
in diameter. Automated particle selection and classiﬁcation revealed a
relatively uniform size distribution (Fig. 7B), with some classes having
the appearance expected for monomers, while a few classes displayed
what appeared to be two adjacent CFTR monomers. These may repre-
sent transient but favored CFTRparticle associations, andwere excluded
from the subsequent analysis. Reconstruction of 3D volume for eachdataset by standard iterative procedures generated maps (Fig. 7A,
right) with low resolution because of the strong underfocus employed
and the small particle size. In both detergents, CFTR dimensions and
shape were consistent with expectations for an ABC transporter such
as the structurally well characterized mitochondrial ABC transporter
ABCB10 (the superimposed ribbon diagram in Fig. 7A) [42].
Size exclusion chromatography (SEC) detects highmolecularweight
complexes with high sensitivity, provided they remain in solution. CFTR
partially puriﬁed inDDM,MNG10, FA-4, or C12E8was progressively con-
centrated by ultraﬁltration, sampling the retentates at intermediate
concentrations along the way. SEC analysis with ﬂuorimetric detection
showed that, for each detergent tested, CFTR eluted predominantly in
a single peak (Fig. 8A), with small amounts eluting as higher molecular
weight multimers (leading edge shoulder) or at the void volume. This
monodispersity distribution, showing only small amounts of oligomer
or aggregate, was consistent with our EM results which were obtained
on virtually identical samples and which clearly showed a predomi-
nance of monomer. Noticeably more CFTR appeared at the void volume
when puriﬁed in C12E8, even at 0.1 mg/ml, the lowest concentration ex-
amined. With progressive concentration of this sample above 1 mg/ml,
highmolecular weight complexes at the void volume grew increasingly
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4 could be concentrated above 2 mg/ml with negligible new accumula-
tion of higher molecular weight complexes.
Because SEC can fail to detect severe aggregation when precipitable
material does not elute from the column, we also assessed the concen-
trated samples using an electrophoretic mobility shift approach to re-
veal irreversible, SDS-resistant aggregates lodged at the top of the gel
(Fig. 8B). Densitometric traces of ﬂuorescent bands on the gel are
shown for samples concentrated to ~1 mg/ml. Results of this mobility
shift analysis largely coincided with the SEC outcome, showing pro-
nounced CFTR monomer bands; there was signiﬁcant evidence of SDS-
resistant multimer or aggregated protein at the top of the separating
gel only in the case of CFTR concentrated in C12E8.
3.6. Stability of CFTR above 1 mg/ml
It is also important to assess the stability of puriﬁed CFTR over the
longer term.We implemented the facile mobility shift assay to monitor
progress of CFTR aggregation over time for a larger number of deter-
gents. Partially puriﬁed CFTR preparations in different detergents were
concentrated by ultraﬁltration.We took samples immediately after con-
centration and again at intervals during storage at 4 °C. As illustrated by
the example in Fig. 9A, SDS-resistant complexes of CFTR accumulated
with time and at different rates depending on the detergent. Evidence
of proteolysis on these gels was negligible both by ﬂuorescent imaging
and by silver staining (data not shown). Using in-gel ﬂuorescence to
quantitate the CFTR monomer band vs. time, we found that its disap-
pearance obeyed ﬁrst-order kinetics (Fig. 9B), and this was the case
for every detergent that we tested. This useful outcome provided a
straightforward way to compare CFTR aggregation rates in the test0.0
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Fig. 7. Puriﬁed, concentrated CFTR is predominantlymonomeric. Panel A: Cryo-electronmicrog
reous buffer. CFTR particles showpredominantlymonomeric particles (darker gray particles). A
excluded from the single particle analysis. To the right are orthogonal views of the ﬁnal 3D ma
protein (ABCB10, PDB: 4ayw). Panel B: The quality of the map was assessed using Fourier she
25 Å. Shown to the right are the projection class averages derived from the raw data with no
3D map (rightmost panel).detergents. Table 4 presents t1/2 values measured for aggregation of
CFTR in a number of detergents. This kinetic analysis demonstrated rel-
atively poor CFTR stability in conventional maltosides such as DDM,
whereas use of MNG10 or Chaps for puriﬁcation produced CFTR prepa-
rations with greater resistance to aggregation. Among the detergents
tested, FA-4 provided the lowest rate of CFTR aggregation, with a t1/2
close to two weeks.
4. Discussion
In structural and biophysical characterization ofmembrane proteins,
detergent choice is critical. We devised a simple, rapid tandem afﬁnity
puriﬁcation scheme and used this to evaluate function, monodispersity,
and stability of CFTR puriﬁed in various detergents. This detergent sur-
vey focused primarily on mild detergents, including recently developed
detergents and amphiphiles, and identiﬁed MNGs and novel facial am-
phiphiles as the most favorable for puriﬁcation of active CFTR and for
achieving the higher protein concentrations that will be required for
its biophysical and structural analysis.
CFTR was originally puriﬁed to homogeneity from insect cells using
SDS, and after lipid addition and extensive dialysis against cholate, sin-
gle channel recordings were demonstrated [43]. ATP hydrolysis was
later demonstrated in CFTR puriﬁed and reconstituted using the same
scheme, with supporting mutant controls even though purity was not
shown in these reports [36,44]. In a direct comparison, O'Riordan et al.
found similar function of CFTR prepared in that puriﬁcation scheme to
CFTR puriﬁed ~70% from Chinese hamster ovary (CHO) cells using
lysoPC for solubilization and chromatography [16]. Introduction of the
polyhistidine afﬁnity tag enabled efﬁcient puriﬁcation of recombinant
CFTR from insect cells [15,17] or yeast [18], but still required harshraphs of CFTR samples puriﬁed in FA-4were concentrated to 3.1 mg/ml and imaged in vit-
fewexamples of larger particles (circled)may represent aggregates or oligomers, andwere
p (yellow transparent surface) into which has been ﬁtted the structural model of an ABC
ll correlation between two subsets of the particles, giving a resolution estimate of about
symmetry applied (center panel). These compare closely with reprojections of the ﬁnal
Fig. 8. Certain detergents support concentration of CFTR above 1 mg/ml without aggregation. Panel A: Size exclusion chromatographywith ﬂuorescent detection. CFTR samples at the in-
dicated concentrationswere diluted into SEC buffer containing0.05%MNG10 shortly before injection. The injection volumewas25 μl. Allﬂuorescent traceswere normalized to peak height
for the main CFTR peak at 1.64 ml. Arrows mark the column void volume at 1.05 ml. Mouse P-glycoprotein-GFP (172 kD) puriﬁed in DDM eluted at 1.75 ml. Soluble protein standards of
669 kD and 158 kD eluted at 1.52 ml and 1.72 ml, respectively. Panel B: Portions of the most highly concentrated samples of CFTR were applied to SDS gels, and in-gel ﬂuorescence was
imaged (insets). These traces, left to right, represent densitometric proﬁles from themidpoint of the stacking gel to below the principal CFTR band at 212 kD. Arrows indicate the top of the
separating gel. A shoulder on the right-hand side of the main peak represents under-glycosylated CFTR that copuriﬁed.
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ful in structural analyses. Recombinant CFTR expression in baby ham-
ster kidney cells or CHO cells allowed modest amounts of CFTR to be
puriﬁed in active form with preferred detergents such as DDM [19,45],
but the puriﬁed protein proved aggregation-prone [28].
The development of amammalian expression systemproviding high
levels of human CFTR at the cell surface [EH, HD, A Mulky, QD, A
Aleksandrov, B Bajrami, PA Diego, X Wu, M Ray, AP Naren, JR Riordan,
X Yao, LJD, ILU and JCK, manuscript in preparation] underpinned our
success in purifying active, monodisperse CFTR, for multiple reasons:
(1) CFTR-enriched startingmaterial, (2) native protein phosphorylation
and glycosylation that inﬂuence CFTR folding, stabilize conformation
and regulate function [13,46,47], (3) proven channel function and prop-
er gating properties of the engineered protein, (4)multiple strategically
placed afﬁnity tags, and (5) a GFP domain enabling CFTR quantitation
even in microsomes, crude extracts, and proteoliposomes. Here we
have shown that CFTR can be readily extracted from this starting mate-
rial using any of a variety of mild detergents at modest detergent:pro-
tein ratios. Minimizing detergent exposure formed the basis of our
puriﬁcation strategy, which prioritizes function rather than recovery.
Yields of pure CFTR with MNG10 or with FA-4 averaged 71 μg or
100 μg per 109 cells, respectively, and with bioreactor cell productionit should be possible to purify sufﬁcient amounts of CFTR for biophysical
characterizations using these procedures. Higher CFTR recoveries ob-
tained using facial amphiphiles for chromatography than MNGs or
other maltoside detergents suggest more facile interaction of epitope
tags with afﬁnity matrices and/or greater short term stability.
Because CFTR hydrolyzes ATP rather slowly, and because it cannot
be selectively assayed, CFTR purity is essential in characterizing this
function. Inhibition experiments demonstrated that the comparatively
rapid antiFlag step removed contaminating azide-sensitive ATPase ac-
tivity present in NiNTA-puriﬁed CFTR preparations. The combination
of NiNTAwith immunoafﬁnity chromatography produces CFTR of sufﬁ-
cient purity for ATPase measurement in the absence of inhibitors. Upon
CFTR reconstitution into proteoliposomes, ATPase activity was 2- to 3-
fold higher using facial amphiphiles for chromatography compared to
MNG10.
Functional assessments of proteoliposome preparations provide
limited information about the state of the protein prior to reconstitu-
tion. We also showed that CFTR puriﬁed in FA-4 or in MNG10 exhibits
robust ATPase activity in thepresence of lipid,without removal of deter-
gent. This ﬁnding suggests that the conformation of the catalytic site,
believed to be a composite of NBD1 and NBD2 domains [5,10–12], re-
mains largely intact in these detergents. Certain other detergents (e.g.
Fig. 9. Apparent ﬁrst-order kinetics allow measurement of CFTR aggregation rates. CFTR
was puriﬁed and concentrated in various detergents, and placed at 4 °C. Samples taken
at the indicated time points were applied to SDS gels, and in-gel ﬂuorescence was imaged.
The 212 kD CFTR monomer was quantitated by densitometry. Representative results are
shown for two detergents, among the detergents listed in Table 4 that were analyzed in
this way. Panel A: Fluorescent image showing time-dependent conversion of CFTRmono-
mer to higher molecular weight, SDS-resistant complexes migrating at the top of the sep-
arating gel and stacking gel, marked by arrowheads. Panel B: A semilog plot of CFTR
monomer concentrations vs. time for the experiment shown inA, demonstrating apparent
ﬁrst order kinetics for CFTR aggregation.
Table 4
Half-life values for aggregation of CFTR puriﬁed in various detergents.
t1/2, days (initial CFTR concentration)
Two experiments
0.05% Mal 12-1 1.4 (0.95 mg/ml) 2.2 (1.4 mg/ml)
0.1% undecylmaltoside 1.9 (1.2 mg/ml) 2.7 (1.8 mg/ml)
0.05% dodecylmaltoside 3.4 (2.0 mg/ml) 2.6 (2.0 mg/ml)
0.05% tridecylmaltoside 2.3 (1.5 mg/ml) nd
0.05% C12E8 3.9 (0.25 mg/ml) 2.1 (0.70 mg/ml)
0.05% Cymal 6 3.4 (0.51 mg/ml) 5.0 (0.94 mg/ml)
0.05% lysoPG14 3.1 (2.2 mg/ml) nd
0.05% lysoPC14 4.4 (1.5 mg/ml) nd
0.05% MNG10 6.4 (0.53 mg/ml) 8.8 (1.1 mg/ml)
1% Chaps 7.4 (1.5 mg/ml) 8.8 (1.9 mg/ml)
0.05% FA-4 12.0 (1.3 mg/ml) 17.0 (1.4 mg/ml)
CFTR was partially puriﬁed by NiNTA chromatography in the indicated detergent. To im-
prove recoveries, UDM was used for solubilization when the detergent for chromatogra-
phy was lysoPG, lysoPC, Chaps or FA-4. Otherwise, a single detergent was used
throughout. CFTR was then concentrated by ultraﬁltration and buffer-exchanged as de-
scribed in Section 2.9. Samples were taken periodically over 7 days of storage at 4 °C for
determination of CFTR monomer concentration by in-gel ﬂuorescence.
nd: not done.
2835E. Hildebrandt et al. / Biochimica et Biophysica Acta 1838 (2014) 2825–2837UDM, Chaps) appeared to exert inhibitory effects. The direct assay is
therefore most suited to carefully chosen detergents. This new stream-
lined assay procedure affords the opportunity to measure activity
promptly, and is readily adaptable to multiwell applications, for exam-
ple in testing whether mutations stabilize the protein.
Others have established the utility of SEC with protein ﬂuorescence
monitoring for proﬁling membrane protein polydispersity [30,48] and
to detect aggregation triggered by thermal treatment [48,49], detergent
exposure [30,50], or other challenges to protein stability. We applied
SEC in an analogous test of CFTR stability in response to the challenge
of concentration by ultraﬁltration in select detergents. CFTR puriﬁed
in DDM, MNG10 or FA-4 exhibits good short-term stability above
1 mg/ml, but somewhat more aggregation takes place in C12E8 during
the process of concentration. Results obtained by examining these sam-
ples for aggregation in our gel mobility shift assay were congruent with
SEC results. Employing electron microscopic techniques, we further
showed that puriﬁed CFTR preparations in MNG or in FA-4 appear pre-
dominantlymonomeric and free of large protein aggregates. Unlike SEC
columns that unavoidably dilute protein samples approximately 10-
fold during analysis, cryoEM analysis provided information about
CFTR monodispersity at original protein concentration. CryoEM also
produced monomeric CFTR particle image galleries compatible with
known ABC transporter structures.
The gel mobility shift assay provided a simple method to quantitate
CFTR resistance to aggregation on the timescale of days. Long-termCFTR
stability varies more widely among detergents, with facial amphiphilesproviding the best long-term stability, followed byMNGor Chaps. Com-
plexmultistep and/or multipathway processes such as protein aggrega-
tion can and often do present apparent ﬁrst order kinetics [51,52], and
indeed CFTR entry into SDS-resistant aggregates obeyed ﬁrst order ki-
netics in many detergents. Because CFTR aggregation rates vary widely
with detergent, it is reasonable to propose that aggregationmaybe rate-
limited by destabilizing interactions with detergent. Biophysical studies
showed the individual NBD domains to be highly sensitive to detergent,
and nucleotide photoafﬁnity labeling indicated this also to be the case
with full-length CFTR [14]. Nonetheless, other solution components
that might contribute to instability were not investigated in the present
study. Manipulation of buffer conditions should be explored to further
stabilize CFTR against aggregation over the long term.5. Conclusions
Afﬁnity-tagged CFTR expressed in HEK293 cells can be solubilized
and rapidly puriﬁed to homogeneity using mild detergents. Conditions
have been identiﬁed that allowmeasurement of ATPase activity of puri-
ﬁed CFTR without detergent removal. Novel facial amphiphiles and
neopentyl maltoside detergents support CFTR function, monodispersity,
and stability above 1 mg/ml for many days — an achievement expected
to advance the ﬁeld. These protocols can be used to generate samples
of pure, active CFTR at concentrations amenable to biophysical
characterization.Author contributions
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